← Feed

TRAVERSA SERGIO

SEC Form 4 insider
Chief Executive Officer · RELMADA THERAPEUTICS, INC. ($RLMD)
1 thesis · first seen Sep 11, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$RLMDSEC Form 4bullish
TRAVERSA SERGIO · Chief Executive Officer at RELMADA THERAPEUTICS, INC. · 2h agono track record yet
Long 200,000 shares of RLMD
Bought 200,000 @ $4.14 avg · $828,000 · 2026-09-09

Form 4: TRAVERSA SERGIO bought RLMD

TRAVERSA SERGIO (Chief Executive Officer at RELMADA THERAPEUTICS, INC.) reported an open-market purchase of 200,000 shares of RLMD at an average $4.14, roughly $828,000, in a Form 4 filed 2026-09-11.

Now $4.428m ago
View filing on SEC.gov →

End of results.